Clinical Trial Update: A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study assessing the interaction between rifampin and vinflunine in subjects with advanced cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• RIFAMPIN (RIFAMPIN)
• Vinflunine (vinflunine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: WITHDRAWN